Chimera Investment Corporation (CIM) Earnings Call Transcript & Summary

November 3, 2022

New York Stock Exchange US Real Estate Mortgage Real Estate Investment Trusts (REITs) earnings 26 min

Earnings Call Speaker Segments

Victor Falvo

executive
#1

Thanks, operator, and I appreciate all of you joining us for Chimera's Third Quarter 2022 Earnings Conference Call. Prior to getting started, I want to walk through the safe harbor statements. On this call, we'll be sharing forward-looking statements, meaning predictions, projections or other statements regarding future events; such statements rest on present expectations and assumptions that carry risks and uncertainties, which are described in the Risk Factors section of our latest annual and quarterly SEC filings. Actual events and results could diverge materially from those forward-looking statements; we urge you to review the forward-looking statement disclaimer included in our earnings release as well as our quarterly and annual filings. Today's call will also cover non-GAAP financial measures. For reconciliation to the most comparable GAAP measures, please see our SEC filings and earnings supplement. In addition, what's said on this conference call may include time-sensitive information that holds true only as of the date of this earnings call; we do not undertake and specifically disclaim any obligation to update or revise this information. At this point I'll hand the conference over to our CEO and Chief Investment Officer, Mohit Marria.

Mohit Marria

executive
#2

Good morning, everyone, and thanks for joining the Third Quarter 2022 Earnings Call for Chimera Investment Corporation. Here with me today are Choudhary Yarlagadda, our President and Chief Operating Officer; Subra Viswanathan, our Chief Financial Officer; and Vic Falvo, our Head of Capital Markets. Following my comments, Subra will go through the financial results, and after that we'll take your questions. Before we get started, I want to congratulate every Chimera employee along with the members of our Board of Directors, both past and present, as we mark 15 years since becoming a New York Stock Exchange listed company. The team we've assembled makes me very proud, and I greatly appreciate everything they've contributed to this company. Market volatility was elevated during the third quarter, which pushed rates higher and spreads wider, adding more pressure on our book value, yet we think this has opened up a number of opportunities for Chimera on both sides of the balance sheet. Specifically, through the end of October, we've managed to grow our cash position, expand the amount of non-mark-to-market financing, and either added or committed to add new investments to our portfolio. This has been a busy stretch for us, and I'll get into more detail on that shortly. But first, let me walk through the broader market and how that maps to our portfolio and our expectations. Capital markets have swung around this year, hit by global conflicts, high inflation, a quickly rising interest rate environment and a weakening U.S. economy. Inflation, which Federal Reserve officials thought last year was transitory in nature, has proven persistent, with the consumer price index hitting 8.3% on a year-over-year basis in September. Consequently, the Federal Reserve lifted interest rates 75 basis points at both their July and September meetings, which brought total tightening of short-term interest rates to 300 basis points across the first 9 months of this year. The size and speed of the Fed tightening has pushed prices down for all fixed income products, among them treasuries, corporate bonds and mortgage-backed securities. Higher rates throughout the capital markets have passed through to the consumer, with the rate on 30-year conforming mortgages climbing to 7.04% at quarter end compared with 3.18% 1 year ago. Higher mortgage rates have significantly slowed new home purchases and wiped out refinance activity. As reported in September, existing home sales fell for 8 consecutive months to the lowest level in the past decade. So we believe this year's mortgage rate shock to the consumer will help slow down the economy and ultimately result in lower rates, since many consumers will have less disposable income to spend. Chimera's portfolio of residential mortgage credit is unique and differentiated amongst our peers; it is well seasoned and has been through many interest rates and economic cycles. We hold approximately $1.2 billion of non-agency RMBS, which is largely made up of opportunistic purchases made after the previous housing crisis. For quite a while now, this portfolio has delivered double-digit returns for us, and we anticipate that will keep being the case going forward. Starting in 2014, we've built up an $11.8 billion book of residential mortgage loans whose features differ considerably from what's typically available via the mortgage banking channels banks use and through traditional mortgage-backed security investors. Within our loan portfolio there are 115,000 loans, with the typical balance sitting at $102,000. On average, these loans are 15-year seasoned, and at origination the average loan to value came to 83%. Something significant: 88% of the loans we hold were originated in 2007 or before, meaning these homeowners have spent 15 years or more making payments on their homes; on top of that, the portfolio spans many geographies, with just 3 states showing concentrations above 5%. Taken as a whole, this portfolio stands apart. Because the loan size is small, monthly mortgage payments stay low. Thanks to how old the loans are, plenty of these homeowners have had a fairly lengthy stretch of time to benefit from home price appreciation and/or mortgage amortization, and there's an extended, proven record of the homeowner making monthly mortgage payments. Every one of these elements matters greatly when assessing a mortgage borrower's capacity to pay. This seasoned reperforming portfolio serves as the foundation of our business, and we're confident that our holdings of seasoned reperforming loans will keep beating the market. In our view, today's market conditions — higher interest rates along with wider mortgage spreads — create fresh accretive investment possibilities. Since the year began, we've been gradually scaling into new investments. Our patience and investment discipline across this year, we believe, will pay off for our shareholders over the long term. Now let me walk you through what we've been doing lately. In the third quarter of 2022, we committed to purchasing $687 million of residential mortgage loans, and $211 million out of that amount settled in October. We anticipate closing $476 million of loans into a long-term non-mark-to-market structure, which we expect will produce double-digit returns. Because settlement was delayed, we figure the full benefit from these loans will show up in 2023. On top of that, during the third quarter of 2022 we bought and settled $66 million of business purpose loans. As we've noted before, we favor the loan characteristics that come with business purpose loans. They carry short duration and deliver solid spread income for the portfolio; altogether, we committed to purchasing $753 million of loans in the third quarter. At quarter's end, 96% of our capital was allocated to residential credit assets. Securitizations continue to be the main way we finance our loans. In September, we sponsored CIM 2022-R3. Our rated securitization of seasoned reperforming residential mortgage loans, with a principal balance of $370 million. Securities issued by CIM 2022-R3 carrying an aggregate balance of roughly $284 million were sold through a private placement to institutional investors. Those senior securities made up approximately 77% of the capital structure. We kept subordinated notes along with some interest-only securities, and together those have a total balance of roughly $86 million. In addition, we held onto an option allowing us to call the securitized mortgage loans, exercisable whenever we choose starting in September of 2027. For this securitization, our debt carries an average cost of 5.80%. By the close of the quarter, securitized debt made up 72% of all our financing, with an average cost of 2.7%, and 98% of that securitized debt is fixed rate. Mostly as a result of securitization during this quarter, we brought down our overall recourse financing by $328 million. On the other 28% of our financing, we have retained some of our secured credit financing in facilities that are either non mark-to-market or limited mark-to-market. During this quarter, we pushed out a maturing $489 million non-mark-to-market facility, adding 29 months so it now runs to February of 2025. Our view remains that these facilities are valuable pieces of our liability structure. Interest rate volatility rose considerably in the third quarter. With the market expecting rates to stay higher for a longer stretch, we put in place a $500 million 2-year interest rate swap and a $385 million 5-year interest rate swap. These swaps work alongside the $1 billion swaption we took out in Q2, which lets us partially hedge our borrowing cost across a longer horizon.

Mohit Marria

executive
#3

Our derivative hedge book is going to be run alongside the way we handle assets and liabilities. All told, in Q3 we put on $885 million of pay-fixed interest rate swaps. Then after the quarter closed, we finished October holding roughly $350 million in cash on the balance sheet, and we added another $1.1 billion of pay-fixed interest rate swaps. We also signed a fresh 2-year non-mark-to-market secured financing facility worth $250 million, meant to fund retained securities out of our securitizations, and we sponsored $145 million CIM 2022-NR1 using existing loans from our warehouse; taken together, these moves have made Chimera's liability and liquidity standing even stronger since the quarter ended. All through 2022, we've run the balance sheet so as to secure long-term funding while hunting for chances to bring higher-yielding mortgage assets into the portfolio. We've kept recourse leverage lower and held firm to our practice of using non or limited mark-to-market financing for a great many of our subordinate credit assets. And even though markets have proven difficult from the start of the year, we have closed or committed to acquire $1.6 billion of loans, finished 5 securitizations amounting to $1.6 billion, bought back $50 million of our common stock, put on close to $3 billion in hedge transactions as protection against additional rate increases, and we expect to bring on new credit financing partners, lifting non and limited mark-to-market facilities to almost 50% of secured financing. Our credit portfolio, we believe, is solid, and it will keep beating other mortgage assets available in the marketplace. Chimera firmly believes in securitization. It gives us stable, nonrecourse long-term financing. We've taken plenty of actions to shore up our balance sheet so we can ride out the present economic storm. We think we're well positioned to seize the new opportunities the market offers, and that our patience and investment discipline will pay off for shareholders over the long term. I'll now hand the call to Subra to go over the quarter's financial results.

Subramaniam Viswanathan

executive
#4

Thanks, Mohit. I'll walk through Chimera's results for Q3 2022. When the third quarter closed, GAAP book value stood at $7.44 per share, and the economic return we recorded on that GAAP book value came in at negative 13%, calculated from the quarter-over-quarter movement in book value plus the dividend declared on common shares for Q3. Our GAAP net loss during Q3 totaled $205 million, equal to $0.88 per share; measured on an earnings available for distribution basis, net income for Q3 reached $63 million, or $0.27 per share. Economic net interest income for Q3 came to $104 million. During Q3, average interest-earning assets produced a yield of 5.5%. We faced an average cost of funds of 3%, leaving a net interest spread of 2.5%. Leverage on a total basis for Q3 was 3.9:1, and recourse leverage finished the quarter at 1.1:1. For the quarter, annualized economic net interest return on average equity was 14.8%. Annualized GAAP return on average equity, meanwhile, was negative 26.5%. Finally, Q3 expenses—leaving out servicing fees and transaction expenses—amounted to $15 million, in line with the prior quarter. That wraps up what we wanted to cover. We're ready to take your questions now.

Kenneth Lee

analyst
#5

There's quite a bit happening on the financing front, with the extension of the non-mark-to-market and the rate swaps you've been putting in place. I was hoping you could share some thoughts on how funding costs might move in the near term, given all of these developments? And more importantly, how sensitive would funding costs be if rates rise?

Mohit Marria

executive
#6

Ken, it's Mohit here. Good question. When we came into 2022, the Fed was expected to go from where it began to where it would finish, with roughly 3 to 4 rate hikes in magnitude. As we said in the opening remarks, they've clearly gone well beyond that. And yesterday, they added another 75 basis points, bringing the Fed funds rate to 4%; and because expectations about the Fed's path shifted so fast, that's why we began laddering into swaps and hedges to shield our financing costs during the last 2 quarters and even after quarter end. So the bulk of our recourse borrowings carry a floating rate. That means any movement in the index and the Fed fund rate turns into higher financing costs. However, these hedges will lock in a rate over the coming 2, 3 years, locked in together with the spreads this finance on. Still, from a spread standpoint, when it comes to the asset we're looking to finance, there's still plenty of cash at those spreads to finance those assets. So it's really the benchmark rate rather than the spread that worries us more.

Kenneth Lee

analyst
#7

Thank you — I'd like to ask one more question, if that's alright. I found the conversation about RPLs helpful, and I understand that a large portion of the residential loans have significant seasoning. Still, could you address what a decelerating housing market and possible declines in home prices might mean for how resi loans are valued, or for non-agency valuations?

Mohit Marria

executive
#8

Certainly. What really sets our loan portfolio apart is how extensively seasoned it is. At origination, the LTV stood at 83%. Assuming 85% of that portfolio was originated before 2007, you've got 15 years of natural amortization working in your favor, plus fairly robust HPA. As a result, we estimate the LTV on the portfolio — once updated, or adjusted for HPI and amortization — sits nearer to 50%. From the perspective of credit performance, that leaves considerable equity as a cushion, and when you consider the average loan balance of $102,000, the monthly mortgage payment comes in below $800. Now, compare that with how mortgage rates have moved from the beginning of the year until today: on a $400,000 mortgage, the payment would shift by $900. These borrowers have lived through various interest rate cycles and credit events, so in our view, given how few housing alternatives are available to them, the change should not be material.

Trevor Cranston

analyst
#9

Could you discuss the way the significant turbulence in the rates market has affected your willingness to invest, particularly because of the danger that a substantial shift in rates and spreads might occur during the interval from when you buy loans to when the securitization is completed?

Mohit Marria

executive
#10

Trevor, that is once more a solid question, and something we have covered on some other calls too. Our method isn't really to accumulate loans in mini bulk amounts where we purchase bulk production and hold them in warehouse in order to move servicing and eventually securitize; thus, from the point of committing to a trade through funding that trade to securitization, we tend to view it on a 60- to 90-day basis in terms of turnaround. So we aim to constrain the exposure we carry to spread and rates changing. This year, though, has stood out because of how fast rates shifted in Q3. The 2-year went up 130 basis points, the 5-year rose 100 basis points, and the 10-year increased 90-ish basis points. That turned it into a somewhat difficult environment, on top of how much issuance there was in the new issue market. Still, we do assume warehousing risk and leverage it as much as we can, with the quick turnaround I just referenced.

Trevor Cranston

analyst
#11

All right, understood. Then, in that update after the quarter closed, you brought up the $476 million of loans — I believe that's how you described them — which would be put into a long-term non-mark-to-market structure. Could you clarify precisely what that means? And what's the reason for using it instead of securitization?

Mohit Marria

executive
#12

Certainly. As you just brought up, and as I told the person asking the earlier question, because of the difficulties in the new issue market right now, we picked up these loans and simultaneously secured a 5-year tenure financing arrangement, done on a non-mark-to-market basis, reaching an advance rate comparable to what a securitization would provide. Thus, in our view, this was the superior result for generating stronger returns for the company.

Trevor Cranston

analyst
#13

So do you see structures of that kind potentially becoming more accessible soon, should the market for new issues not appear quite so appealing?

Mohit Marria

executive
#14

That's right. What I'd say is that, once again, with the difficulties the market for new issues is up against, such structures might well grow more usual. And when the securitization side of things does come back, at that point we'll look to strike a balance as we move ahead.

Trevor Cranston

analyst
#15

All right, understood. Then for the final item, could you give us an update on book value for the quarter so far?

Mohit Marria

executive
#16

Certainly. Well, once more, this same question has come up during the past 2 quarters. And on each occasion, the way you laid it out, things looked quite a bit different by the time the quarter wrapped up. Following quarter end, rates shifted roughly 30 basis points in a parallel move along the curve. Spreads have widened slightly. My expectation would be that book value has declined somewhere in the range of 2% to 3% from quarter end.

Mike Smyth

analyst
#17

Michael Smyth here, filling in for Bose. To start off, could you give us an update regarding the pipeline for acquiring assets and, more broadly, how competitive things currently are in this area? I'd also like to know whether any of the partners you originate loans with has pulled back, considering how volatility has picked up. Then, as a second question, please remind us of the total count of loan origination partners you work with. And if some of them are closing up shop or dealing with solvency trouble, just given how rates keep shifting.

Mohit Marria

executive
#18

Of course, Mike. When it comes to sourcing assets, there's no issue there. As we've mentioned before, we've taken a defensive stance, working to keep leverage low while bringing in accretive assets. We've purchased $1.6 billion in loans since the year began. And clearly, we've completed 5 securitizations as a way to finance a large portion of those deals. Our approach is to bid on loans based on where the securitization exit stands and/or where we're able to locate alternative long-term financing options for them. There's no flow agreement in place with anyone; we purchase based on whatever delivers the greatest economic sense from an ROE standpoint for the company; so once more, we hold no commitment with any specific originators when it comes to sourcing assets on a flow basis. Everyone, I'd say, reaches out to us so we can select the collateral we prefer; so I hope that addresses your question.

Mike Smyth

analyst
#19

Yeah, that helps. Maybe just one more thing, then. Could you spend a moment on what levered ROEs look like for new investments? And then how do you weigh the trade-off between playing offense, repurchasing shares, and keeping liquidity strong?

Mohit Marria

executive
#20

Absolutely; I'll take the ROE part first. On those loans expected to close in Q4, the $476 million, we said the return on that investment would be double-digit. Most of the mortgage ecosystem, in my view, can generate quite appealing levered returns; however, with rates elevated, inflation still acting as a drag, and the Fed staying active, our approach to putting capital to work will remain quite disciplined. Holding liquidity steady is, I'd say, the top priority for us, just as it has been all year. We entered the year at 1.0 turns of recourse leverage. Now we're at 1.1, and rates have shifted by 300 to 400 basis points along the curve; even so, we also want to be equally focused on allocating accretive capital, since certain investments look so attractive. That said, on the whole, a levered return ought to be in the mid-teens at minimum before we'd allocate capital, and plenty of opportunities exist there right now, as things stand.

Mohit Marria

executive
#21

Appreciate it, operator, and thanks to all of you for being with us on today's call; we're eager to talk with you again next year.

Operator

operator
#22

Thanks. That brings us to the end of today's call. We appreciate everyone for joining in. At this point, you're welcome to hang up your phones, and enjoy the rest of your day.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Chimera Investment Corporation transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

For developers and AI pipelines

Programmatic access to Chimera Investment Corporation earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Chimera Investment Corporation or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.